We are live on
!
Find out more
Creative Planning Portfolio holdings
AUM
$147B
1-Year Est. Return
18.73%
This Fund
S&P 500
This Quarter
Est. Return
+0.26%
1 Year Est. Return
+18.73%
3 Year Est. Return
+48.71%
5 Year Est. Return
+44.71%
10 Year Est. Return
+145.34%
AUM
$30.7B
AUM Growth
+$988M
(+3.3%)
Cap. Flow
+$1.01B
Cap. Flow
% of AUM
3.28%
Top 10 Holdings %
Top 10 Hldgs %
54.65%
Holding
2,179
New
164
Increased
802
Reduced
752
Closed
188
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core US Aggregate Bond ETF
AGG
|
+$124M |
| 2 |
WisdomTree Emerging Markets SmallCap Dividend Fund
DGS
|
+$122M |
| 3 |
Alerian MLP ETF
AMLP
|
+$112M |
| 4 |
Vanguard FTSE Developed Markets ETF
VEA
|
+$84.3M |
| 5 |
Schwab International Equity ETF
SCHF
|
+$75.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AMJ
JP Morgan Alerian MLP Index ETN 5/24/24
AMJ
|
+$92.7M |
| 2 |
TSS
Total System Services, Inc.
TSS
|
+$49.4M |
| 3 |
Vanguard Mid-Cap ETF
VO
|
+$25.4M |
| 4 |
Schwab US REIT ETF
SCHH
|
+$23.4M |
| 5 |
Apple
AAPL
|
+$14.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 4.77% |
| 2 | Technology | 4.11% |
| 3 | Healthcare | 1.86% |
| 4 | Consumer Discretionary | 1.76% |
| 5 | Industrials | 1.7% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1251
Teradata
TDC
$2.68B
| $359K | ﹤0.01% |
11,596
-2,854
| -20% | -$96.3K |
|
1252
Motley Fool 100 Index ETF
TMFC
$2B
| $359K | ﹤0.01% |
15,987
-84
| -0.5% | -$1.9K |
|
|
CVGW
1253
DELISTED
Calavo Growers
CVGW
| $358K | ﹤0.01% |
3,758
+807
| +27% | +$74.1K |
|
1254
NCR Voyix
VYX
$1.06B
| $358K | ﹤0.01% |
18,468
-323
| -2% | -$6.24K |
|
1255
First Trust NASDAQ Clean Edge Green Energy Index Fund
QCLN
$633M
| $357K | ﹤0.01% |
16,671
-1,165
| -7% | -$25.2K |
|
1256
Sun Life Financial
SLF
$45.6B
| $357K | ﹤0.01% |
7,957
-53
| -0.7% | -$2.21K |
|
1257
Alaunos Therapeutics
TCRT
$4.74M
| $357K | ﹤0.01% |
555
-46
| -8% | -$36.5K |
|
1258
Assured Guaranty
AGO
$3.78B
| $356K | ﹤0.01% |
8,000
-1,045
| -12% | -$46K |
|
1259
Akamai
AKAM
$16.8B
| $356K | ﹤0.01% |
3,896
+935
| +32% | +$81.2K |
|
1260
Revvity
RVTY
$12.3B
| $356K | ﹤0.01% |
4,176
-169
| -4% | -$14.8K |
|
|
VRNT
1261
DELISTED
Verint Systems
VRNT
| $356K | ﹤0.01% |
16,356
-159
| -1% | -$4.23K |
|
1262
HNI Corp
HNI
$3B
| $355K | ﹤0.01% |
10,000
+4,000
| +67% | +$133K |
|
1263
State Street SPDR S&P 400 Mid Cap Growth ETF
MDYG
$2.82B
| $354K | ﹤0.01% |
6,586
+1,075
| +20% | +$58K |
|
1264
Bio-Techne
TECH
$11.2B
| $354K | ﹤0.01% |
7,232
+92
| +1% | +$4.61K |
|
1265
Chemed
CHE
$6.78B
| $353K | ﹤0.01% |
845
+23
| +3% | +$9.39K |
|
1266
MDU Resources
MDU
$4.44B
| $353K | ﹤0.01% |
32,921
-878
| -3% | -$8.96K |
|
|
CSII
1267
DELISTED
Cardiovascular Systems, Inc.
CSII
| $352K | ﹤0.01% |
7,404
-200
| -3% | -$9.4K |
|
1268
Carlisle Companies
CSL
$13.6B
| $351K | ﹤0.01% |
2,412
+428
| +22% | +$60.1K |
|
1269
Sensata Technologies
ST
$6.65B
| $351K | ﹤0.01% |
7,012
-719
| -9% | -$34K |
|
1270
CGI
GIB
$13.9B
| $350K | ﹤0.01% |
4,427
-18
| -0.4% | -$1.4K |
|
|
HIX
1271
Western Asset High Income Fund II
HIX
$352M
| $348K | ﹤0.01% |
51,393
-810
| -2% | -$5.54K |
|
|
ACBI
1272
DELISTED
Atlantic Capital Bancshares, Inc. Common Stock
ACBI
| $347K | ﹤0.01% |
20,000
| – | – |
|
1273
DXC Technology
DXC
$1.63B
| $345K | ﹤0.01% |
11,679
+2,105
| +22% | +$89.7K |
|
|
SNV
1274
DELISTED
Synovus
SNV
| $345K | ﹤0.01% |
9,645
-3,682
| -28% | -$132K |
|
1275
Anika Therapeutics
ANIK
$199M
| $343K | ﹤0.01% |
6,254
-8,944
| -59% | -$459K |
|
Similar funds
Creative Planning's Q3 2019 Portfolio in Review
As of Q3 2019, Creative Planning held 2,179 positions worth $30.7B, up 3.3% from $29.7B the previous quarter. Its ten largest holdings account for 55% of the portfolio.
Creative Planning deployed $1.01B of net new capital in Q3 2019, opening 164 new positions and adding to 802 existing holdings. Its largest new stake was Oncternal Therapeutics, Inc. Common Stock: 23,872 shares worth $2.39M.
By sector, the portfolio is most concentrated in Financials at 4.8% of assets, down from 4.9% a quarter earlier, followed by Technology and Healthcare.
On the sell side, the largest reduction was JP Morgan Alerian MLP Index ETN 5/24/24, an estimated $92.7M trimmed.
- Creative Planning's largest Q3 2019 buy was Oncternal Therapeutics, Inc. Common Stock: 23,872 shares worth $2.39M.
- Creative Planning added most to iShares Core US Aggregate Bond ETF in Q3 2019, an estimated $124M increase.
- Creative Planning's biggest Q3 2019 reduction was JP Morgan Alerian MLP Index ETN 5/24/24, cutting an estimated $92.7M.
- Creative Planning fully exited Total System Services, Inc. in Q3 2019, selling an estimated $49.4M.
- Creative Planning's ten largest holdings make up 55% of its $30.7B portfolio in Q3 2019.
- Creative Planning opened 164 new positions and closed 188 in Q3 2019.
- Creative Planning's portfolio value rose 3.3% quarter-over-quarter to $30.7B.
Based on Creative Planning's 13F filing for Q3 2019, filed 1 Nov 2019.